Early Evaluation of Left Ventricular Systolic Function Impairment in Patients With Chronic Kidney Disease by Multimodal Ultrasonography
1 other identifier
observational
500
1 country
1
Brief Summary
The goal of this observational study is to learn about the value of multimodal ultrasound in early detection of left ventricular systolic dysfunction in patients with chronic kidney disease(CKD). The main questions it aims to answer are:
- 1.If first-phase ejection fraction(EF1)could early detect the left ventricular systolic dysfunction in patients with CKD.
- 2.Whether EF1 can detect left ventricular systolic dysfunction in patients with CKD more sensitively than speckle-tracking echocardiography and myocardial work.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 16, 2024
CompletedFirst Posted
Study publicly available on registry
January 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 11, 2024
April 1, 2024
1.3 years
January 16, 2024
April 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
first-phase ejection fraction
an ultrasound indicator used to assess early left ventricular systolic function
1 hour
Study Arms (2)
case group
This group contains the patients with chronic kidney disease.
control group
This group contains the healthy adults.
Eligibility Criteria
Patients with chronic kidney disease who are hospitalized in The Fifth Affiliated Hospital of Sun Yat-sen University.
You may qualify if:
- Patients with chronic kidney disease who are hospitalized in The Fifth Affiliated Hospital of Sun Yat-sen University.
- LVEF≥50%.
You may not qualify if:
- Patients with primary hypertension, diabetes and congenital heart disease.
- Patients who are pregnant or lactating.
- Patients with the blurry ultrasound images.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Fifth Affiliated Hospital of Sun Yat-sen University
Zhuhai, Guangdong, 519000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 16, 2024
First Posted
January 24, 2024
Study Start
October 1, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2025
Last Updated
April 11, 2024
Record last verified: 2024-04